Doctor profile · Federal record
Dr. Ravi Vij, MD
Medical Oncology Physician (CMS: Medical Oncology) · Saint Louis, MO
- NPI 1023034337
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4500 Forest Park Ave, Div Im Bone Marrow Transplant, 5Th, 6Th, 8Th Fl
Saint Louis, MO 631082114
(314) 454-8304
fax (314) 454-5902 - Mailing address
-
Po Box 7412011
Chicago, IL 606742011
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- April 17, 2025
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Missouri #110997
- Medicaid
- MO #205173404
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023034337. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
45,783
Distinct HCPCS
10
Medicare allowed
$1,576,336
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,760 | 31 | $48 | |
J9271 |
Injection, pembrolizumab, 1 mg | 6,800 | 12 | $54 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 4,500 | 11 | $13 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,200 | 21 | $0 | |
J9025 |
Injection, azacitidine, 1 mg | 4,000 | 12 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,880 | 19 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,665 | 72 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,155 | 15 | $6 | |
J2353 |
Injection, octreotide, depot form for intramuscular injection, 1 mg | 780 | 12 | $203 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 750 | 42 | $1 |
In context: peer comparison
Among 44 peers in Saint Louis Medical Oncology Physician, average services per provider: 919. This provider delivers 50× the peer median.Open Payments
Industry payments received
All-time total
$34,818
Transactions
19
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $6,400.00 | |
| Genzyme Corporation | 4 | $6,008.56 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $5,324.50 | |
| Karyopharm Therapeutics INC. | 1 | $4,075.00 | |
| Pfizer INC. | 2 | $3,670.00 | |
| Sanofi US Services INC. | 1 | $2,991.00 | |
| Janssen Global Services, LLC | 1 | $2,700.00 | |
| Janssen Scientific Affairs, LLC | 1 | $1,650.00 | |
| Dr.Reddy's Laboratories,INC. | 1 | $1,250.00 | |
| Janssen Research & Development, LLC | 1 | $287.50 | |
| Janssen Biotech, INC. | 2 | $261.65 | |
| Sobi, INC | 1 | $200.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,326
Patients
326
Total drug cost
$6,721,135
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 224 | 61 | $6,910 |
| Revlimid (Lenalidomide) | Brand | 142 | 26 | $2,756,927 |
| Pomalyst (Pomalidomide) | Brand | 126 | 22 | $2,686,452 |
| Dexamethasone | Generic | 125 | 39 | $1,655 |
| Oxycodone Hcl | Generic | 119 | 44 | $3,203 |
| Gabapentin | Generic | 109 | 24 | $1,469 |
| Lenalidomide | Generic | 80 | 17 | $1,212,891 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 78 | 25 | $3,914 |
| Ondansetron Hcl | Generic | 53 | 27 | $619 |
| Oxycontin (Oxycodone Hcl) | Brand | 53 | 0 | $41,111 |
Hospital affiliations
Frequently asked questions
What is Dr. Ravi Vij's medical specialty?
Dr. Ravi Vij practices Medical Oncology Physician in Saint Louis, MO.
Where does Dr. Ravi Vij practice?
Dr. Ravi Vij practices at 4500 Forest Park Ave, Saint Louis, MO 631082114. Office phone: 3144548304.
What is Dr. Ravi Vij's NPI?
Dr. Ravi Vij's National Provider Identifier (NPI) is 1023034337, issued by NPPES.
Does Dr. Ravi Vij accept Medicare assignment?
Yes. Dr. Ravi Vij accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ravi Vij commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, paclitaxel protein-bound particles, 1 mg (HCPCS J9264). Source: CMS Medicare Physician & Other Practitioners file.